Trial
NCT03476928
A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bayer
Collaborators
—
Condition
Uterine Fibroids and Heavy Menstrual Bleeding
Intervention
Vilaprisan (BAY1002670)
Why stopped
Due to a change in the development program, the study was closed prematurely.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-08